Articles tagged with "trial"

Rheumatology Drug Updates: Efficacy Studied Following Accelerated Drug Approvals; Plus Secukinumab Meets Benchmark for Psoriasis

November 9, 2017 • By Michele B. Kaufman, PharmD, BCGP

Abatacept Approved for Psoriatic Arthritis in Adults; Sirukumab Approval Stalls

September 17, 2017 • By Michele B. Kaufman, PharmD, BCGP

Rheumatology Drug Updates: Opana ER Painkiller Pulled from U.S. Market; Upadacitinib to Treat RA, and More

August 13, 2017 • By Michele B. Kaufman, PharmD, BCGP

Baricitinib Effective for Treating Refractory Rheumatoid Arthritis

February 15, 2017 • By Mary Beth Nierengarten

Rheumatology Drug Updates: Giant Cell Arteritis Relapse Possible if Tocilizumab Discontinued; Plus Updates on Rituximab, Etanercept

January 19, 2017 • By Michele B. Kaufman, PharmD, BCGP

Rheumatology Drug Updates: Ixekizumab Improves Work Productivity, plus Vobarilizumab Completes Phase 2 Trial in Rheumatoid Arthritis

September 9, 2016 • By Michele B. Kaufman, PharmD, BCGP

Rheumatology Drug Updates: Opioid CR845 for OA Pain; RA Treatments in Development

March 15, 2016 • By Michele B. Kaufman, PharmD, BCGP

FOCIS 2015: Research Increases Understanding of Lupus, RA

October 13, 2015 • By Catherine Kolonko

FOCIS 2015: TET Protein Regulation May Provide Insights for Cancer Treatment

September 15, 2015 • By Catherine Kolonko

EULAR 2015: Problems with Biomarkers

September 15, 2015 • By Thomas R. Collins